You need to upgrade your Flash Player To view the flash content contained in this page you will need to download the latest flash player from the Adobe website.

Clinical Trials Manufacturing at Moorfields Pharmaceuticals

At Moorfields Pharmaceuticals we believe that our offering is unique, the ability to manufacture and supply clinical trial materials in extremely short lead-times.

Our confidence in delivering this offering is founded on twenty plus years of delivering outstanding service to our unlicensed medicines customers. Many of our unlicensed medicines are manufactured, released and delivered to our ultimate customer, the patient, within 48 hours of the order being received. As a result, our business systems are tuned to being flexible, reliable and reactive.

The need for flexible, reliable and reactive business systems is equally applicable to the supply of clinical trials materials. Timely completion of clinical trials is essential to either maximise future commercial revenue streams or to divert monies from an unsuccessful drug candidate to other potential blockbuster drugs.

The facilities at Moorfields Pharmaceuticals are ideally equipped to serve your clinical trials manufacturing needs.

For Phase 1 clinical trials manufacturing, we would recommend our semi-manual filling operation which is performed under a Class A environment, with a Class B background. Baxa filling pumps are used to achieve the required filling accuracy whilst the filled vials are sealed using an automated crimping unit of cap applicator.
For Phase 2 clinical trials manufacturing, our semi-manual filling operation would be suitable for smaller quantities whilst our automated vial filling process is ideal for large quantities. The automated process uses a Bausch and Strobel KSF 1020 filler, protected by a Class A environment with a Class B background.
For Phase 3 clinical trials manufacturing, we would recommend our automated vial filling process.

Both semi-manual and automated filling processes offer the added flexibility of aseptic filling or terminally sterilisation post-filling.

Our semi-manual filling process is especially suited to Phase 1 clinical trials manufacturing where API availability is often limited. Our innovative approach to process optimisation enables maximal yield conversion to be realised.

Contact us to discuss your clinical trials needs and to experience an organisation which is small enough to care but big enough to deliver.

moorfields pharmaceuticals image of clinical trials